Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression

US Patent 11839614 · Granted Dec 12, 2023

Estimated economic value: $52,827,000

Assignee

Inventors

View full patent text on Google Patents →